DexCom Company Description

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally.

The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application.

It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

DexCom, Inc.

Country	United States
Founded	1999
Industry	Medical Devices
Sector	Healthcare
Employees	11,050
CEO	Jacob Leach

Contact Details

Address: 6340 Sequence Drive San Diego, California 92121 United States
Phone	858 200 0200
Website	dexcom.com

Stock Details

Ticker Symbol	D1EX34
Exchange	Brazil Stock Exchange
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	3845

Key Executives

Name	Position
Jacob Steven Leach	President, Chief Executive Officer and Director
Kevin Ronald Sayer	Executive Chairman of the Board (Leave of Absence)
Michael Jon Brown	Executive Vice President and Chief Legal Officer
Sadie M. Stern	Executive Vice President and Chief Human Resources Officer
Girish Naganathan	Executive Vice President and Chief Technology Officer
Sean Christensen	Vice President of Finance and Investor Relations
Matthew Dolan	Executive Vice President of Strategy and Corporate Development
Donald M. Abbey	Executive Vice President of Global Business Services, Regulatory, Medical and Clinical Affairs
Jon Coleman	Executive Vice President and Chief Commercial Officer
Keri Leone	Senior Director of Global Medical Science and Education